1適應(yīng)證隆突重建術(shù)最常見的指征是侵犯隆突的良、惡性腫瘤,腫瘤可能原發(fā)于氣管,可直接生長于隆突,也可從肺部浸潤而來。術(shù)前必須嚴(yán)格排除是否有轉(zhuǎn)移灶或其他禁忌證。右側(cè)隆突重建術(shù)最多見,絕大多數(shù)情況下從右支氣管遠(yuǎn)端切緣...[繼續(xù)閱讀]

    1.MathisenDJ,GrilloHC.Carinalresectionforbronchogeniccarcinoma.JThoracCardiovascSurg,1991,102:16～232.MitchellJC,MathisenDJ,WrightCD,WainJC,DonahueDM,MoncureAC,GrilloHC.Clinicalexperiencewithcarinalresection.JThoracCardiovascSurg,1999,117:39～533.MitchellJD...[繼續(xù)閱讀]

    1概述影像學(xué)隱性肺癌(ROLCs)的定義是X線或胸部CT未發(fā)現(xiàn)實性病灶的支氣管肺癌。日本肺癌協(xié)會提出了早期肺門肺癌的定義,需符合以下條件:①病灶位于段支氣管的近端;②腫瘤浸潤局限于支氣管壁;③沒有淋巴結(jié)轉(zhuǎn)移或遠(yuǎn)處轉(zhuǎn)移證據(jù)。...[繼續(xù)閱讀]

    1概述目前多發(fā)性肺轉(zhuǎn)移瘤切除術(shù)已成為其標(biāo)準(zhǔn)的治療手段,在滿足手術(shù)條件的病人中,預(yù)計超過三分之一的病人能獲得長期生存(>5年)。20世紀(jì)80年代晚期,胸腔鏡手術(shù)運用于孤立性肺轉(zhuǎn)移瘤的診斷和治療的價值被認(rèn)識,尤其在多發(fā)性肺...[繼續(xù)閱讀]

    1.PattersonEJ,ScudmoreCH,BuczowskiAK,etal.Radiofrequencythermalablationinsurgery.SurgOverview,SurgTechnolInt,1997,6:69～752.RosenthalDI,HornicekFJ,WolfeMW,etal.Percutaneousradiofrequencycoagulationofosteoidosteomacomparedwithoperativetreatment.JBoneJointSu...[繼續(xù)閱讀]

    1.MarkJ.Krasna,M.D.XiaolongJiao,M.D.ThoracoscopicandLaparoscopicStagingforEsophagealCancerCTSNETExpertsTechniques,GeneralThoracicExpertsTechniquesAmericanJointCommitteeonCancer,TaskForceonEsophagus:Manualforstagingofcancer,Edition4,Philadelphia;JBLippinco...[繼續(xù)閱讀]

    1.陳克能,徐光煒.食管癌的診斷和治療.世界華人消化雜志,2000,8(2):196～2022.AkaishiT,KanedaI,HiguchiN,KuriyaY,KuramotoJ,ToyodaT,WakabayashiA.Thoracoscopicen-bloctotalesophagectomywithradicalmediastinallymphadenectomy.JThoracCardiovacsSurg,1996,112,1533～15413.AkiyamaH,TsurumeruM,...[繼續(xù)閱讀]

    1概述食管從解剖學(xué)上由沒有固有名稱的血管提供血供,只有從周圍組織和器官上分支出來的側(cè)枝血管供血。這是在非直視下鈍性剝出全食管的解剖學(xué)基礎(chǔ)。這特征被胸外科醫(yī)師利用從而創(chuàng)造出食管剝脫術(shù)和經(jīng)裂孔食管切除術(shù)兩種方式...[繼續(xù)閱讀]

    1概述日本外科醫(yī)生自1980年起便對食管鱗狀細(xì)胞癌開展了三野清掃(three-fieldlymphnodedissection,TFD)。幾個來自日本的報道表明術(shù)前大約1/3患者有明確的頸部淋巴結(jié)轉(zhuǎn)移。1997年,MarkK.Ferguson開始了小型受控試驗,以評價該技術(shù)的可能性,并對病...[繼續(xù)閱讀]

    1.AltorkiNKandSkinnerD.Shoulden-blocesophagectomybethestandardofcareforesophagealcarcinoma?AnnSurg,2001,234:581～5872.AltorkiNK,LerutT.Three-fieldlymphnodedissectionforcanceroftheesophagus.PearsonFG,CooperJD,DeslauriersJ,GinsbergRJ,HiebertCA,PattersonGA,an...[繼續(xù)閱讀]